Interchange Capital Partners’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.7K | Sell |
18,307
-5,256
| -22% | -$6.52K | 0.01% | 280 |
|
|
2025
Q1 | $27.8K | Sell |
23,563
-6,433
| -21% | -$7.59K | 0.01% | 269 |
|
|
2024
Q4 | $52.9K | Buy |
29,996
+1,034
| +4% | +$1.83K | 0.02% | 245 |
|
|
2024
Q3 | $49.2K | Sell |
28,962
-2,237
| -7% | -$3.8K | 0.02% | 256 |
|
|
2024
Q2 | $42.7K | Buy |
31,199
+2,558
| +9% | +$3.5K | 0.02% | 260 |
|
|
2024
Q1 | $114K | Buy |
28,641
+9,932
| +53% | +$39.6K | 0.08% | 167 |
|
|
2023
Q4 | $184K | Buy |
18,709
+1,991
| +12% | +$19.5K | 0.14% | 148 |
|
|
2023
Q3 | $140K | Buy |
16,718
+4,058
| +32% | +$33.9K | 0.11% | 147 |
|
|
2023
Q2 | $168K | Buy |
+12,660
| New | +$168K | 0.13% | 147 |
|
|
2022
Q3 | – | Sell |
-10,506
| Closed | -$46K | – | 167 |
|
|
2022
Q2 | $46K | Sell |
10,506
-713
| -6% | -$3.12K | 0.05% | 153 |
|
|
2022
Q1 | $102K | Buy |
+11,219
| New | +$102K | 0.1% | 155 |
|